Missing data refers to information that is not available for a particular observation or participant in a clinical study. This can occur when data is not collected, lost, or when participants drop out of a study before its completion.
Missing data can pose significant challenges in clinical research, potentially introducing bias and affecting the validity of study results. Researchers must carefully account for and address missing data using appropriate statistical methods to ensure the integrity of their analyses and conclusions.
Missing data is crucial in clinical research because it can significantly impact the validity and reliability of study results. Failing to properly address missing data can lead to biased estimates, reduced statistical power, and potentially incorrect conclusions about treatment efficacy or safety.
Understanding and managing missing data is essential for maintaining the integrity of clinical trials and ensuring regulatory compliance. Proper handling of missing data demonstrates the robustness of research methodologies and enhances the credibility of findings, which is critical for drug development and approval processes.
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Copyright @ 2026 Axcellant